Appian and PSI CRO Launch AI Site Selection Tool for Trials
BERLIN – October 29, 2026 -- Appian (Nasdaq: APPN) and contract research organisation PSI have taken a live AI-powered process orchestration solution for clinical trial site identification and selection into operation, the first joint project between the two companies.
The solution covers therapeutic areas, indications and geographies. It moves previously manual, decentralised steps into a single digital process, from project initiation through the later stages of site selection.
Solution orchestrates site selection across teams and countries
Site selection involves multiple stakeholders, large volumes of documentation and parallel activities across regions. The new tool connects people, data, systems and AI in one workflow, and coordinates activities across teams and geographies. It automates information and document processing, manages routing and exceptions, and provides real-time insight into process performance.